Other
Nasal Placebo
Nasal Placebo is an intervention with 4 clinical trials. Historical success rate of 75.0%.
Total Trials
4
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
75.0%
Based on 3 completed trials
Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Terminated
1(25%)
Phase Distribution
Ph phase_2
2
50%
Ph phase_1
1
25%
Ph not_applicable
1
25%
Phase Distribution
1
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
2(50.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Terminated(1)
Detailed Status
Completed3
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
75.0%
Most Advanced
Phase 2
Trials by Phase
Phase 11 (25.0%)
Phase 22 (50.0%)
N/A1 (25.0%)
Trials by Status
terminated125%
completed375%
Recent Activity
0 active trials
Showing 4 of 4
terminatedphase_2
Aztreonam Aerosol to Treat Cystic Fibrosis Nasal Disease
NCT02730793
completedphase_1
A Comparison of Two Sedation Techniques in Children Undergoing Transthoracic Echocardiography (TTE)
NCT02250820
completednot_applicable
Nasal Tramazoline and Dexamethazone in Obstructive Sleep Apnea (OSA) Patients Tramazoline and
NCT01601509
completedphase_2
A Study of Nasal PYY3-36 and Placebo for Weight Loss in Obese Subjects
NCT00537420
Clinical Trials (4)
Showing 4 of 4 trials
NCT02730793Phase 2
Aztreonam Aerosol to Treat Cystic Fibrosis Nasal Disease
NCT02250820Phase 1
A Comparison of Two Sedation Techniques in Children Undergoing Transthoracic Echocardiography (TTE)
NCT01601509Not Applicable
Nasal Tramazoline and Dexamethazone in Obstructive Sleep Apnea (OSA) Patients Tramazoline and
NCT00537420Phase 2
A Study of Nasal PYY3-36 and Placebo for Weight Loss in Obese Subjects
All 4 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 4